Search

Search Constraints

You searched for: Author/Creator Colbers, Angela

Search Results

1. 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study. Issue 8 (August 2022)

2. Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action. (19th July 2022)

3. Adequate exposure of 50 mg dolutegravir in children weighing 20 to 40 kg outside of sub-Sahara Africa. (15th November 2022)

5. Advancing the prevention and treatment of HIV in children: priorities for research and development. Issue 9 (September 2022)

6. Atazanavir Exposure is Effective during Pregnancy Regardless of Tenofovir Use. Issue 1 (January 2015)

7. Brief Report: Pharmacokinetics of Crushed Elvitegravir Combination Tablet Given With or Without Enteral Nutrition. (15th April 2017)

8. Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change. (1st May 2023)

9. Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change. (1st May 2023)

10. Clinical and population‐based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy. (19th July 2022)